The full content of Annals is available to subscribers

Subscribe/Learn More  >
Letters |

Cimetidine and Acute Intermittent Porphyria

Jose Halabe Cherem, MD; Jose Malagon, MD; and Haiko Nellen, MD
[+] Article, Author, and Disclosure Information

From Hospital de Especialidades, Centro Médico Nacional Siglio XXI IMSS, 06720 Mexico D.F.

Potential Financial Conflict of Interest: None disclosed.

Ann Intern Med. 2005;143(9):694-695. doi:10.7326/0003-4819-143-9-200511010-00023
Text Size: A A A





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Cimetidine and acute intermittent porphyria
Posted on November 4, 2005
Gabriele Rossi
University of Pavia, 27100 Pavia, Italy
Conflict of Interest: None Declared

In the interesting report "Cimetidine and Acute Intermittent Porphyria", Cherem and colleagues, demonstrating the effectiveness of cimetidine for the treatment of acute porphyric crisis and for the long- term prophylaxis, point out the need to conduct larger studies to confirm these encouraging results. (1) However, attention should be paid for those patients suffering from an acute neurological porphyric attack (50-55% of the total attacks) characterized by the presence of psychiatric symptoms, such as anxiety, insomnia, agitation, hallucinations, delirium, confusion and psychosis. (2) Indeed, it is known that histamine-2 receptor (H2) blockers, and in particular cimetidine, may be associated with the development of the same neurological side effects (3), and, therefore, can possibly contribute to exacerbate and worsen the clinical situation. Moreover, several reports have documented an association between the chronic use of cimetidine and the rising of a depressive syndrome (4), which can represent a long-term complication of acute intermittent porphyria and a major risk factor for suicide, one of the most important and frequent cause of death seen in this disease. (2,5)

1) Cherem JH, Malagon J, Nellen H. Cimetidine and acute intermittent Porphyria [Letter]. Ann Intern Med. 2005;143:694-5. [PMID:16263899]

2) Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005;142:439-50. [PMID: 15767622]

3) Cantu TG, Korek JS. Central nervous system reactions to histamine- 2 receptor blockers. Ann Intern Med. 1991;114:1027-34. [PMID: 1674198]

4) Petite JP, Bloch F. Depressive syndrome during cimetidine treatment [Letter]. Nouv Presse Med. 1979;8:1260. [PMID: 440948]

5) Jeans JB, Savik K, Gross CR, Weimer MK, Bossenmaier IC, Pierach CA, et al. Mortality in patients with acute intermittent porphyria requiring hospitalization: a United States case series. Am J Med Genet. 1996;65:269- 73. [PMID: 8923933]

Conflict of Interest:

None declared

Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.